Fibrocystic breast disease conventional modern medicine
Have you been told you have fibrocystic breasts? About half of women develop them at some point in their lives. The condition can be painful, but it's a benign condition that's neither a symptom nor a risk factor for breast cancer. Instead, fibrocystic breast tissue features lumpy or rope-like textures that are completely healthy. The name "fibrocystic breast disease" used to be common, but now doctors are more likely to call it simply "fibrocystic breasts" or "fibrocystic breast changes" because it's not a disease. The primary symptom of fibrocystic breasts is the lumpy, rope-like texture.
Fibrocystic Breast Disease – Treatment and Prevention
Fibrocystic Breast Disease - Treatment and Prevention | Thermography Rochester
Tamoxifen is a drug that has been in worldwide use for the treatment of estrogen receptor ER -positive breast cancer for over 30 years; it has been used in both the metastatic and adjuvant settings. Despite these positive findings, however, the public's attitude toward breast cancer chemoprevention remains ambivalent, and the toxicities associated with tamoxifen, particularly endometrial cancer and thromboembolic events, have hampered the drug's uptake by high-risk women who should benefit from its preventive effects. Among the strategies to overcome such obstacles to preventive tamoxifen, two novel and potentially safer modes of delivery of this agent are discussed in this paper. Low-dose tamoxifen, expected to confer fewer adverse events, is being investigated in both clinical biomarker-based trials and observational studies.
This is part one of a series of five articles designed to explore the integration of traditional Chinese medicine TCM in the treatment of breast cancer. Part one will detail the results of clinical trials from China. Part three will discuss secondary prevention of breast cancer and part four will outline TCM pattern differentiation for breast cancer pathogenesis. The series will relate what is known scientifically as well as the authors clinical experience and current understanding of the disease. It will start with dry facts and culminate with the experiential and speculative.
This is a corrected version of the article that appeared in print. A thorough clinical breast examination, imaging, and tissue sampling are needed for a definitive diagnosis. Fine-needle aspiration is fast, inexpensive, and accurate, and it can differentiate solid and cystic masses.